X

Vous n'êtes pas connecté

Maroc Maroc - Times of India - Life & Style - 13/12/2024 17:13

A simple pill can soon cure diabetes: Scientists

Researchers at Mount Sinai are developing a revolutionary pill using harmine, a DYRK1A inhibitor, to regenerate insulin-producing beta cells in the pancreas. Harmine alone tripled beta cell mass, and combined with a GLP-1 agonist like Ozempic, increased it by 700%. The team discovered that alpha cells could potentially be transformed into beta cells, offering a new source for insulin production.

Articles similaires

New pathway explains poor response to bladder cancer immunotherapy

news.medical.net - 19/Mar 02:05

Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have discovered a biological pathway that helps...

Vitamin B2 metabolism helps cancer cells resist ferroptosis

news.medical.net - 14/Mar 02:43

A lack of vitamin B2 makes tumour cells more susceptible to a unique form of cell death. This was discovered by researchers at the Rudolf Virchow...

Sorry! Image not available at this time

Daily pill may cure deadly sleep disorder that affects 84 million people

wn.com - 13/Mar 19:42

Researchers have discovered that an existing drug could be the breakthrough cure for a condition impacting 30 million people in the US, which until...

Sorry! Image not available at this time

Daily pill may cure deadly sleep disorder that affects 84 million people

wn.com - 13/Mar 19:42

Researchers have discovered that an existing drug could be the breakthrough cure for a condition impacting 30 million people in the US, which until...

Sorry! Image not available at this time

2018 to 2025 Saw Rise in GLP-1 Receptor Agonist Rx for Bariatric Surgery-Eligible Patients

drugs.com - 10/Mar 15:03

TUESDAY, March 10, 2026 -- Among patients eligible for metabolic and bariatric surgery (MBS), glucagon-like peptide-1 receptor agonist (GLP-1 RA)...

Sorry! Image not available at this time

Persistence With GLP-1 Receptor Agonist Therapy Remains Low Among Those With Overweight, Obesity

drugs.com - 12/Mar 23:07

THURSDAY, March 12, 2026 -- Less than 25 percent of adults with overweight or obesity without diabetes remain on any glucagon-like peptide-1 receptor...

Sorry! Image not available at this time

Claudio Villanueva | Fat cells burn energy to make heat – making them the next frontier of weight loss therapies

jamaica-gleaner.com - 11/Mar 18:13

Over the past few years, a new class of medications has transformed the treatment of obesity. Drugs like Ozempic, Wegovy and Mounjaro work primarily...

Sorry! Image not available at this time

Study Finds GLP‑1 Therapy Reduces Heart and Kidney Risks for Type 1 Diabetes Patients

wn.com - 16:59

The results suggest that the five-year risk of major cardiovascular events such as heart attacks and the risk of end-stage kidney disease were reduced...

Sorry! Image not available at this time

GLP-1 Receptor Agonists Linked to Lower Mortality for Patients With Brain Metastases, T2DM

drugs.com - 13/Mar 15:10

FRIDAY, March 13, 2026 -- For patients with cancer and brain metastases (BM) and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist...

Sorry! Image not available at this time

Preterm Birth Up With Periconceptional GLP-1 Receptor Agonist Exposure for Diabetes

drugs.com - 23/Mar 16:03

MONDAY, March 23, 2026 -- Periconceptional exposure to glucagon-like peptide-1 (GLP-1) receptor agonists is associated with increased odds of preterm...